Tag: Neuroscience
PharmaSignal — Neuroscience therapeutic area
Otsuka picks up PTSD drug with $700M Transcend buy
March 27, 2026
BioPharma Dive
The buyout, which includes another $525 million in floated payouts, hands Otsuka a medicine it sees as a possibly paradigm-shifting therapy in psychiatry.
How former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup
March 24, 2026
BioPharma Dive
Cohen says he looked at around two dozen companies since Acorda wound down.